Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
2.18B
-
Number of holders
-
1150
-
Total 13F shares, excl. options
-
162M
-
Shares change
-
-6.53M
-
Total reported value, excl. options
-
$14.9B
-
Value change
-
-$599M
-
Put/Call ratio
-
0.47
-
Number of buys
-
411
-
Number of sells
-
-557
-
Price
-
$92.00
Significant Holders of NOVARTIS AG - Ordinary Shares (NVS) as of Q1 2023
1,269 filings reported holding NVS - NOVARTIS AG - Ordinary Shares as of Q1 2023.
NOVARTIS AG - Ordinary Shares (NVS) has 1,150 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 162M shares
of 2.18B outstanding shares and own 7.45% of the company stock.
Largest 10 shareholders include Dodge & Cox (20.3M shares), PRIMECAP MANAGEMENT CO/CA/ (16.4M shares), BANK OF AMERICA CORP /DE/ (7.6M shares), FRANKLIN RESOURCES INC (6.98M shares), MORGAN STANLEY (6.61M shares), LOOMIS SAYLES & CO L P (6.61M shares), DIMENSIONAL FUND ADVISORS LP (6.17M shares), WELLINGTON MANAGEMENT GROUP LLP (4.85M shares), GOLDMAN SACHS GROUP INC (4.65M shares), and CHARLES SCHWAB INVESTMENT MANAGEMENT INC (4.46M shares).
This table shows the top 1150 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.